Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 99.36% is 26% above its 5-year average of 78.76%, near the high end of its 5-year range (48.51%–100.00%).
0.03% below its 12-month average of 99.39%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
99.36%
GROSS MARGIN AVG TTM
99.39%
GROSS MARGIN AVG 3Y
81.09%
GROSS MARGIN AVG 5Y
78.76%
GROSS MARGIN AVG 10Y
81.76%
GROSS MARGIN AVG 15Y
77.90%
GROSS MARGIN AVG 20Y
74.05%
CURRENT VS TTM AVG
-0.03%
CURRENT VS 3Y AVG
+22.52%
CURRENT VS 5Y AVG
+26.15%
CURRENT VS 10Y AVG
+21.53%
CURRENT VS 15Y AVG
+27.55%
CURRENT VS 20Y AVG
+34.18%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+140.12%
vs the sector median at left
Nektar Therapeutics
Market Cap
$1.14B
Gross Margin
99.36%
TTM Avg
99.39%
3Y Avg
81.09%
5Y Avg
78.76%
Market Cap
$1.14B
Gross Margin
88.05%
TTM Avg
93.34%
3Y Avg
92.32%
5Y Avg
92.94%
Market Cap
$1.13B
Gross Margin
73.28%
TTM Avg
75.19%
3Y Avg
72.82%
5Y Avg
72.76%
Market Cap
$1.13B
Gross Margin
47.68%
TTM Avg
50.27%
3Y Avg
51.23%
5Y Avg
48.58%
Market Cap
$1.12B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.20B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.10B
Gross Margin
56.01%
TTM Avg
52.19%
3Y Avg
51.27%
5Y Avg
51.81%
Market Cap
$1.10B
Gross Margin
76.23%
TTM Avg
76.19%
3Y Avg
76.96%
5Y Avg
77.39%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nektar Therapeutics (NKTR) | $1.14B | 99.36% | 99.39% | 81.09% | 78.76% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.14B | 88.05% | 93.34% | 92.32% | 92.94% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 73.28% | 75.19% | 72.82% | 72.76% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 47.68% | 50.27% | 51.23% | 48.58% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.12B | 0.00% | 0.00% | 0.00% | 0.00% |
| Replimune Group, Inc. (REPL)vs › | $1.10B | 0.00% | 0.00% | 0.00% | 0.00% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.20B | 0.00% | 0.00% | 0.00% | 0.00% |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.10B | 56.01% | 52.19% | 51.27% | 51.81% |
| STAAR Surgical Company (STAA)vs › | $1.10B | 76.23% | 76.19% | 76.96% | 77.39% |
| OPKO Health, Inc. (OPK)vs › | $1.10B | 21.10% | 32.36% | 32.56% | 33.45% |
Gross Margin
99.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 98.61% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 98.34% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 72.66% |
| 2024-09-30 | 81.62% |
| 2024-06-30 | 58.53% |
| 2024-03-31 | 60.56% |
| 2023-12-31 | 69.51% |
| 2023-09-30 | 48.51% |
| 2023-06-30 | 65.88% |
| 2023-03-31 | 67.31% |
| 2022-12-31 | 71.70% |
| 2022-09-30 | 78.95% |
| 2022-06-30 | 76.30% |
| 2022-03-31 | 78.59% |
| 2021-12-31 | 75.36% |
| 2021-09-30 | 78.69% |
| 2021-06-30 | 72.94% |
| 2021-03-31 | 75.66% |
| 2020-12-31 | 81.57% |
| 2020-09-30 | 81.45% |
| 2020-06-30 | 88.18% |
| 2020-03-31 | 92.46% |
| 2019-12-31 | 82.31% |
| 2019-09-30 | 83.14% |
| 2019-06-30 | 78.48% |
| 2019-03-31 | 80.72% |
| 2018-12-31 | 81.27% |
| 2018-09-30 | 82.77% |
| 2018-06-30 | 99.49% |
| 2018-03-31 | 82.52% |
| 2017-12-31 | 89.78% |
| 2017-09-30 | 96.29% |
| 2017-06-30 | 74.01% |
| 2017-03-31 | 75.21% |
| 2016-12-31 | 82.37% |
| 2016-09-30 | 80.64% |
| 2016-06-30 | 76.48% |
| 2016-03-31 | 84.94% |
| 2015-12-31 | 78.76% |
| 2015-09-30 | 88.72% |
| 2015-06-30 | 53.51% |
| 2015-03-31 | 92.24% |
| 2014-12-31 | 67.79% |
| 2014-09-30 | 93.06% |
| 2014-06-30 | 82.09% |
| 2014-03-31 | 60.01% |
| 2013-12-31 | 71.23% |
| 2013-09-30 | 78.86% |
| 2013-06-30 | 85.20% |
| 2013-03-31 | 49.31% |
| 2012-12-31 | 65.53% |
| 2012-09-30 | 60.74% |
| 2012-06-30 | 69.59% |
| 2012-03-31 | 51.49% |
| 2011-12-31 | 65.47% |
| 2011-09-30 | 81.39% |
| 2011-06-30 | 53.03% |
| 2011-03-31 | 71.12% |
| 2010-12-31 | 77.41% |
| 2010-09-30 | 83.53% |
| 2010-06-30 | 88.51% |
| 2010-03-31 | 87.07% |
| 2009-12-31 | 74.55% |
| 2009-09-30 | 44.33% |
| 2009-06-30 | 21.23% |
| 2009-03-31 | 47.49% |
| 2008-12-31 | 64.04% |
| 2008-09-30 | 75.05% |
| 2008-06-30 | 66.03% |
| 2008-03-31 | 37.16% |
| 2007-12-31 | 63.44% |
| 2007-09-30 | 51.25% |
| 2007-06-30 | 40.09% |
| 2007-03-31 | 33.52% |
| 2006-12-31 | 41.14% |
| 2006-09-30 | 46.82% |
| 2006-06-30 | 38.94% |
| 2006-03-31 | 68.94% |
| 2005-12-31 | 66.10% |
| 2005-09-30 | 74.69% |
| 2005-06-30 | 71.63% |
| 2005-03-31 | 81.56% |
| 2004-12-31 | 80.71% |
| 2004-09-30 | 84.32% |
| 2004-06-30 | 76.40% |
| 2004-03-31 | 90.18% |
| 2003-12-31 | 89.05% |
| 2003-09-30 | 87.06% |
| 2003-06-30 | 86.64% |
| 2003-03-31 | 81.89% |
| 2002-12-31 | 93.30% |
| 2002-09-30 | 91.64% |
